U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07821554) titled 'Personalised Nutritional Care in Older Patients With Pancreatic Ductal Adenocarcinoma' on Aug. 29.
Brief Summary: NutriCa65-PDAC is a clinical study for patients aged 65 years or older with pancreatic ductal adenocarcinoma, a type of pancreatic cancer. Many patients with pancreatic cancer experience weight loss, reduced appetite, loss of muscle mass, dehydration, digestive problems, taste changes, fatigue and reduced quality of life. These problems may affect how patients tolerate cancer treatment and how well they function in daily life.
The purpose of this study is to find out whether early, structured and personalised nutrition...